News Conference News HRS 2025 VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy Todd Neale April 29, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Daily News HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation Todd Neale April 24, 2025
News Conference News EHRA 2025 Positive Results With Volt Pulsed-Field Ablation System Todd Neale April 07, 2025
News Conference News EHRA 2025 Uncertainties Remain About Same-Day Discharge After AF Ablation Todd Neale March 30, 2025
News Daily News Fasting Not Needed Before Cath Lab Procedures: Meta-analysis Todd Neale March 11, 2025
News Daily News J&J Restarts Varipulse Pulsed-Field Ablation Cases in the US Todd Neale February 18, 2025
Presentation Controversies and Advances 2025 Debate: In 2025, Who Should Get Catheter Ablation for Atrial Fibrillation? Presenter: Edward P. Gerstenfeld January 31, 2025
News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Daily News J&J Halts Varipulse Pulsed-Field Ablation Cases in the US Todd Neale January 08, 2025
News Opinion Conversations in Cardiology All Eyes on PCI—Should Patients’ Family Members Watch Cases? December 19, 2024
News Conference News AHA 2024 Two Trials Provide Insights Into Catheter Ablation Options for Persistent AF Todd Neale November 21, 2024
News Daily News No Big Jumps in Smartwatch Accuracy for AF Detection Over Time Todd Neale November 20, 2024
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
Presentation AHA 2024 Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation Presenter: Oussama M. Wazni November 16, 2024
News Conference News AHA 2024 First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2 Caitlin E. Cox November 16, 2024
Presentation AHA 2024 Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial Presenter: John Sapp November 16, 2024
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024